Customs and Border Protection (CBP) officers in Cincinnati, in partnership with the U.S. Food and Drug Administration (FDA), have intercepted significant counterfeit weight loss drugs, as reported by Local12. The seized shipments included bogus versions of Ozempic, Wegovy, and Trulicity injections, which are highly demanded due to their efficacy in aiding weight loss. The operation led to confiscating nearly $270,000 worth of these fake medications.
According to details provided by a FOX19 report, CBP spokesperson Steven Bansbach stated that 63 shipments had been seized containing counterfeit and unapproved drugs that originated from various countries such as China, South Korea, India, Italy, Guatemala, the United Kingdom, and Canada. These countries boast advanced pharmaceutical industries, which makes it concerning that they are a source of fraudulent drugs. Further exacerbating concerns, these drugs often evade the rigorous FDA review process and may contain unknown or dangerous ingredients.
The shipments were flagged in Cincinnati but were destined for distribution across several American states, namely Indiana, Michigan, and Pennsylvania. The CBP closely monitors imports to combat the illegal trade of counterfeit pharmaceuticals, an effort echoed by LaFonda D. Sutton-Burke, Director Field Operations-Chicago, who told Local12, "Cheap prices are not always the safest, especially when it comes to your health and wellbeing.”
In a statement obtained by FOX19, Dan Solis, FDA Assistant Commissioner for Import Operations, highlights the danger of counterfeit and fraudulent prescription drugs, remarking, "The drugs have not undergone the proper FDA review, testing and many contain unknown or dangerous ingredients." Consumers are urged by CBP to only purchase medications from reputable sources and to ensure that any pharmaceuticals are administered by trained and licensed medical professionals, a step considered essential for maintaining health and safety standards.
